James Fadiman received his PhD from Stanford University, where he conducted some of the earliest controlled research on psychedelics in the 1960s before federal prohibition halted the field. He went on to co-found the Institute of Transpersonal Psychology (now Sofia University) and spent decades studying altered states, personal growth, and what he called "problem-solving" sessions using psychedelics.
His most influential contribution to modern psychedelic science is the systematic collection and analysis of microdosing reports. Beginning around 2010, Fadiman began soliciting structured self-reports from individuals around the world who were microdosing psychedelics — mostly psilocybin and LSD — and developed the protocol that bears his name from patterns in this data. His 2011 book The Psychedelic Explorer's Guide introduced the concept to a broad audience and catalyzed the global interest in microdosing research.
Fadiman's 1966 dissertation at Stanford — supervised by Willis Harman — was one of the first experimental investigations of psychedelics and problem-solving, measuring their effects on creative performance in professional architects, engineers, and scientists. The results were striking: participants generated novel solutions to design problems they had been stuck on for months. The study was cut short by federal scheduling, but Fadiman spent the following decades collecting what the research system could not: tens of thousands of first-person reports from self-directed psychedelic users worldwide.
His 2011 book "The Psychedelic Explorer's Guide" synthesized this observational database into practical guidance for different psychedelic protocols — including a specific description of microdosing that would ignite a global phenomenon. The "Fadiman Protocol" (one day on, two days off, repeated for four to eight weeks) became the default starting point for most of the hundreds of thousands of people who began microdosing psilocybin in the 2010s, and the implicit structure for most subsequent research designs.
Critics of his methodology correctly note that observational self-report data cannot establish causation. Fadiman himself has been careful to frame his work as preliminary and anecdotal. His contribution is not the controlled trial — it is the careful documentation of a large-scale natural experiment that pointed researchers toward questions worth investigating. The microdosing research now accumulating in academic settings owes its formulation of the hypothesis, and often its specific protocol parameters, to his decades of patient observation.